Global Central Vascular Access Device Market Report (2025–2036)
Market Overview
The global central vascular access device market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Increasing prevalence of chronic diseases requiring long-term intravenous therapy, rising demand for chemotherapy and parenteral nutrition, and advancements in catheter technology are driving market growth. Central vascular access devices are critical in hospitals and non-hospital settings for safe and efficient drug delivery.
Impact of COVID-19
The pandemic disrupted elective procedures in 2020 but increased demand for vascular access devices in critical care settings. Post-pandemic, adoption of advanced catheters with infection-prevention features accelerated, alongside growing emphasis on home-based infusion therapies.
Segmentation Analysis
By Type
· Peripherally Inserted Central Catheters (PICC)
· Centrally Inserted Catheters (Non-tunnelled and Tunnelled)
· Implanted Ports
· Dialysis Catheters
· Midline Catheters
· Others
By Application
· Hospitals
· Non-Hospital Settings (clinics, homecare, ambulatory centers)
· Specialty Oncology Centers
· Dialysis Centers
By Technology
· Conventional Catheters
· Antimicrobial/Antithrombogenic Catheters
· Power-injectable Catheters
Regional Analysis
· North America: Leading market due to high prevalence of cancer and chronic diseases, advanced healthcare infrastructure, and strong presence of key players.
· Europe: Growth supported by government-funded healthcare systems, aging population, and adoption of advanced vascular access technologies.
· Asia-Pacific: Fastest-growing region, driven by rising healthcare investments in China and India, expanding hospital infrastructure, and increasing demand for cost-effective devices.
· South America: Moderate growth, with Brazil leading in adoption of vascular access devices.
· Middle East & Africa: Emerging opportunities with increasing healthcare modernization and demand for affordable infusion therapies.
Key Players
· C. R. Bard Inc. (BD)
· Smiths Medical Inc.
· Teleflex Incorporated
· B. Braun Melsungen AG
· Nipro Corporation
· Edwards Lifesciences
· Terumo Corporation
· Vygon (UK) Ltd.
· Ameco Medical Industries
· AngioDynamics Inc.
· Romsons
· PRODIMED
· Cook Medical
· ICU Medical Inc.
· Medline Industries
· Fresenius Medical Care
Porter’s Five Forces
· Threat of New Entrants: Low, due to regulatory barriers and high R&D costs.
· Bargaining Power of Suppliers: Moderate, with reliance on specialized medical-grade materials.
· Bargaining Power of Buyers: High, as hospitals demand cost-effective yet advanced devices.
· Threat of Substitutes: Moderate, with alternatives like peripheral IV lines for short-term use.
· Industry Rivalry: High, with global players competing on innovation, safety, and pricing.
SWOT Analysis
Strengths: Essential for long-term therapy, strong demand across hospitals and clinics. Weaknesses: Risk of infection and complications, high device costs. Opportunities: Growth in antimicrobial catheters, expansion in emerging markets. Threats: Regulatory hurdles, competition from alternative therapies, counterfeit products.
Trend Analysis
· Rising demand for antimicrobial and antithrombogenic catheters.
· Increasing adoption of power-injectable PICCs and ports.
· Growth in home-based infusion therapies.
· Expansion of eco-friendly and patient-friendly device designs.
Drivers & Challenges
Drivers:
· Rising prevalence of cancer, renal diseases, and chronic conditions.
· Increasing demand for long-term intravenous therapies.
· Advancements in catheter technology.
Challenges:
· High costs limiting accessibility.
· Risk of catheter-related infections.
· Stringent regulatory approval processes.
Value Chain Analysis
· Raw Material Suppliers (medical-grade plastics, alloys, coatings) → Device Manufacturers → Distributors/Hospitals → Clinics/Homecare Patients
· Partnerships with oncology centers and dialysis providers are reshaping the value chain, improving accessibility and patient compliance.
Recommendations for Stakeholders
· Manufacturers: Invest in antimicrobial and power-injectable technologies.
· Healthcare Providers: Standardize infection-prevention protocols and expand homecare infusion services.
· Investors: Focus on Asia-Pacific for high growth potential.
· Policy Makers: Support reimbursement policies and encourage affordable access to vascular access devices.
1. Market Overview of Central Vascular Access Device
1.1 Central Vascular Access Device Market Overview
1.1.1 Central Vascular Access Device Product Scope
1.1.2 Market Status and Outlook
1.2 Central Vascular Access Device Market Size by Regions:
1.3 Central Vascular Access Device Historic Market Size by Regions
1.4 Central Vascular Access Device Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Central Vascular Access Device Sales Market by Type
2.1 Global Central Vascular Access Device Historic Market Size by Type
2.2 Global Central Vascular Access Device Forecasted Market Size by Type
2.3 PICC
2.4 Centrally Inserted Catheters (non-tunnelled and tunnelled)
2.5 Implanted Ports
2.6 Others
3. Covid-19 Impact Central Vascular Access Device Sales Market by Application
3.1 Global Central Vascular Access Device Historic Market Size by Application
3.2 Global Central Vascular Access Device Forecasted Market Size by Application
3.3 Hospital
3.4 Non-Hospital
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Central Vascular Access Device Production Capacity Market Share by Manufacturers
4.2 Global Central Vascular Access Device Revenue Market Share by Manufacturers
4.3 Global Central Vascular Access Device Average Price by Manufacturers
5. Company Profiles and Key Figures in Central Vascular Access Device Business
5.1 C. R. Bard Inc.
5.1.1 C. R. Bard Inc. Company Profile
5.1.2 C. R. Bard Inc. Central Vascular Access Device Product Specification
5.1.3 C. R. Bard Inc. Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.2 Smiths Medical Inc.
5.2.1 Smiths Medical Inc. Company Profile
5.2.2 Smiths Medical Inc. Central Vascular Access Device Product Specification
5.2.3 Smiths Medical Inc. Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.3 Teleflex Incorporated
5.3.1 Teleflex Incorporated Company Profile
5.3.2 Teleflex Incorporated Central Vascular Access Device Product Specification
5.3.3 Teleflex Incorporated Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.4 B. Braun Melsungen AG
5.4.1 B. Braun Melsungen AG Company Profile
5.4.2 B. Braun Melsungen AG Central Vascular Access Device Product Specification
5.4.3 B. Braun Melsungen AG Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.5 Nipro Corporation
5.5.1 Nipro Corporation Company Profile
5.5.2 Nipro Corporation Central Vascular Access Device Product Specification
5.5.3 Nipro Corporation Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.6 Edwards Lifesciences
5.6.1 Edwards Lifesciences Company Profile
5.6.2 Edwards Lifesciences Central Vascular Access Device Product Specification
5.6.3 Edwards Lifesciences Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.7 Terumo Corporation
5.7.1 Terumo Corporation Company Profile
5.7.2 Terumo Corporation Central Vascular Access Device Product Specification
5.7.3 Terumo Corporation Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.8 Vygon (UK) Ltd
5.8.1 Vygon (UK) Ltd Company Profile
5.8.2 Vygon (UK) Ltd Central Vascular Access Device Product Specification
5.8.3 Vygon (UK) Ltd Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.9 Ameco Medical Industries
5.9.1 Ameco Medical Industries Company Profile
5.9.2 Ameco Medical Industries Central Vascular Access Device Product Specification
5.9.3 Ameco Medical Industries Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.10 AngioDynamics Inc.
5.10.1 AngioDynamics Inc. Company Profile
5.10.2 AngioDynamics Inc. Central Vascular Access Device Product Specification
5.10.3 AngioDynamics Inc. Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.11 Romsons
5.11.1 Romsons Company Profile
5.11.2 Romsons Central Vascular Access Device Product Specification
5.11.3 Romsons Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
5.12 PRODIMED
5.12.1 PRODIMED Company Profile
5.12.2 PRODIMED Central Vascular Access Device Product Specification
5.12.3 PRODIMED Central Vascular Access Device Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Central Vascular Access Device Market Size
6.2 North America Central Vascular Access Device Key Players in North America
6.3 North America Central Vascular Access Device Market Size by Type
6.4 North America Central Vascular Access Device Market Size by Application
7. East Asia
7.1 East Asia Central Vascular Access Device Market Size
7.2 East Asia Central Vascular Access Device Key Players in North America
7.3 East Asia Central Vascular Access Device Market Size by Type
7.4 East Asia Central Vascular Access Device Market Size by Application
8. Europe
8.1 Europe Central Vascular Access Device Market Size
8.2 Europe Central Vascular Access Device Key Players in North America
8.3 Europe Central Vascular Access Device Market Size by Type
8.4 Europe Central Vascular Access Device Market Size by Application
9. South Asia
9.1 South Asia Central Vascular Access Device Market Size
9.2 South Asia Central Vascular Access Device Key Players in North America
9.3 South Asia Central Vascular Access Device Market Size by Type
9.4 South Asia Central Vascular Access Device Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Central Vascular Access Device Market Size
10.2 Southeast Asia Central Vascular Access Device Key Players in North America
10.3 Southeast Asia Central Vascular Access Device Market Size by Type
10.4 Southeast Asia Central Vascular Access Device Market Size by Application
11. Middle East
11.1 Middle East Central Vascular Access Device Market Size
11.2 Middle East Central Vascular Access Device Key Players in North America
11.3 Middle East Central Vascular Access Device Market Size by Type
11.4 Middle East Central Vascular Access Device Market Size by Application
12. Africa
12.1 Africa Central Vascular Access Device Market Size
12.2 Africa Central Vascular Access Device Key Players in North America
12.3 Africa Central Vascular Access Device Market Size by Type
12.4 Africa Central Vascular Access Device Market Size by Application
13. Oceania
13.1 Oceania Central Vascular Access Device Market Size
13.2 Oceania Central Vascular Access Device Key Players in North America
13.3 Oceania Central Vascular Access Device Market Size by Type
13.4 Oceania Central Vascular Access Device Market Size by Application
14. South America
14.1 South America Central Vascular Access Device Market Size
14.2 South America Central Vascular Access Device Key Players in North America
14.3 South America Central Vascular Access Device Market Size by Type
14.4 South America Central Vascular Access Device Market Size by Application
15. Rest of the World
15.1 Rest of the World Central Vascular Access Device Market Size
15.2 Rest of the World Central Vascular Access Device Key Players in North America
15.3 Rest of the World Central Vascular Access Device Market Size by Type
15.4 Rest of the World Central Vascular Access Device Market Size by Application
16 Central Vascular Access Device Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Segmentation Analysis
By Type
· Peripherally Inserted Central Catheters (PICC)
· Centrally Inserted Catheters (Non-tunnelled and Tunnelled)
· Implanted Ports
· Dialysis Catheters
· Midline Catheters
· Others
By Application
· Hospitals
· Non-Hospital Settings (clinics, homecare, ambulatory centers)
· Specialty Oncology Centers
· Dialysis Centers
By Technology
· Conventional Catheters
· Antimicrobial/Antithrombogenic Catheters
· Power-injectable Catheters
Regional Analysis
· North America: Leading market due to high prevalence of cancer and chronic diseases, advanced healthcare infrastructure, and strong presence of key players.
· Europe: Growth supported by government-funded healthcare systems, aging population, and adoption of advanced vascular access technologies.
· Asia-Pacific: Fastest-growing region, driven by rising healthcare investments in China and India, expanding hospital infrastructure, and increasing demand for cost-effective devices.
· South America: Moderate growth, with Brazil leading in adoption of vascular access devices.
· Middle East & Africa: Emerging opportunities with increasing healthcare modernization and demand for affordable infusion therapies.
Key Players
· C. R. Bard Inc. (BD)
· Smiths Medical Inc.
· Teleflex Incorporated
· B. Braun Melsungen AG
· Nipro Corporation
· Edwards Lifesciences
· Terumo Corporation
· Vygon (UK) Ltd.
· Ameco Medical Industries
· AngioDynamics Inc.
· Romsons
· PRODIMED
· Cook Medical
· ICU Medical Inc.
· Medline Industries
· Fresenius Medical Care
